These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17572510)

  • 1. Novel activity of an anti-inflammatory cytokine: IL-10 prevents TNFalpha-induced resistance to IGF-I in myoblasts.
    Strle K; McCusker RH; Tran L; King A; Johnson RW; Freund GG; Dantzer R; Kelley KW
    J Neuroimmunol; 2007 Aug; 188(1-2):48-55. PubMed ID: 17572510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prototypical anti-inflammatory cytokine IL-10 prevents loss of IGF-I-induced myogenin protein expression caused by IL-1beta.
    Strle K; McCusker RH; Johnson RW; Zunich SM; Dantzer R; Kelley KW
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E709-18. PubMed ID: 18270299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramide.
    Strle K; Broussard SR; McCusker RH; Shen WH; Johnson RW; Freund GG; Dantzer R; Kelley KW
    Endocrinology; 2004 Oct; 145(10):4592-602. PubMed ID: 15256490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1beta impairs insulin-like growth factor i-induced differentiation and downstream activation signals of the insulin-like growth factor i receptor in myoblasts.
    Broussard SR; McCusker RH; Novakofski JE; Strle K; Shen WH; Johnson RW; Dantzer R; Kelley KW
    J Immunol; 2004 Jun; 172(12):7713-20. PubMed ID: 15187154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-jun N-terminal kinase mediates tumor necrosis factor-alpha suppression of differentiation in myoblasts.
    Strle K; Broussard SR; McCusker RH; Shen WH; LeCleir JM; Johnson RW; Freund GG; Dantzer R; Kelley KW
    Endocrinology; 2006 Sep; 147(9):4363-73. PubMed ID: 16777978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway.
    Frost RA; Nystrom GJ; Lang CH
    Endocrinology; 2003 May; 144(5):1770-9. PubMed ID: 12697682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine-hormone interactions: tumor necrosis factor alpha impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts.
    Broussard SR; McCusker RH; Novakofski JE; Strle K; Shen WH; Johnson RW; Freund GG; Dantzer R; Kelley KW
    Endocrinology; 2003 Jul; 144(7):2988-96. PubMed ID: 12810554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factor and cytokine interactions in myogenesis. Part I. The effect of TNF-alpha and IFN-gamma on IGF-I-dependent differentiation in mouse C2C12 myogenic cells.
    Wieteska-Skrzeczyńska W; Grzelkowska-Kowalczyk K; Tokarska J; Grabiec K
    Pol J Vet Sci; 2011; 14(3):417-24. PubMed ID: 21957736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts.
    Layne MD; Farmer SR
    Exp Cell Res; 1999 May; 249(1):177-87. PubMed ID: 10328964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt phosphorylation is not sufficient for insulin-like growth factor-stimulated myogenin expression but must be accompanied by down-regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation.
    Tiffin N; Adi S; Stokoe D; Wu NY; Rosenthal SM
    Endocrinology; 2004 Nov; 145(11):4991-6. PubMed ID: 15489316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone and the insulin-like growth factor system in myogenesis.
    Florini JR; Ewton DZ; Coolican SA
    Endocr Rev; 1996 Oct; 17(5):481-517. PubMed ID: 8897022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha inhibits insulin-like growth factor I-induced hematopoietic cell survival and proliferation.
    Shen WH; Zhou JH; Broussard SR; Johnson RW; Dantzer R; Kelley KW
    Endocrinology; 2004 Jul; 145(7):3101-5. PubMed ID: 15087433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial synergistic interactions of TNF-alpha and IL-6 in C2 skeletal myoblasts--potential cross-talk with IGF system.
    Al-Shanti N; Saini A; Faulkner SH; Stewart CE
    Growth Factors; 2008 Apr; 26(2):61-73. PubMed ID: 18428025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to TNF-alpha but not IL-1beta impairs insulin-dependent phosphorylation of protein kinase B and p70S6k in mouse C2C12 myogenic cells.
    Grzelkowska-Kowalczyk K; Wieteska-Skrzeczyńska W
    Pol J Vet Sci; 2006; 9(1):1-10. PubMed ID: 16573269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory activity of a globular adiponectin function on RAW 264 cells stimulated by lipopolysaccharide from Aggregatibacter actinomycetemcomitans.
    Kamio N; Akifusa S; Yamaguchi N; Nonaka K; Yamashita Y
    FEMS Immunol Med Microbiol; 2009 Aug; 56(3):241-7. PubMed ID: 19552715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient exposure of human myoblasts to tumor necrosis factor-alpha inhibits serum and insulin-like growth factor-I stimulated protein synthesis.
    Frost RA; Lang CH; Gelato MC
    Endocrinology; 1997 Oct; 138(10):4153-9. PubMed ID: 9322924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines.
    Weiss T; Shalit I; Blau H; Werber S; Halperin D; Levitov A; Fabian I
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1974-82. PubMed ID: 15155187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of Store-Operated Calcium Entry Reduces IL-17/TNF Cytokine-Induced Inflammatory Response in Human Myoblasts.
    Beringer A; Gouriou Y; Lavocat F; Ovize M; Miossec P
    Front Immunol; 2018; 9():3170. PubMed ID: 30693003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of interleukin-8 expression in human prostate cancer cells by insulin-like growth factor-I and inflammatory cytokines.
    Kooijman R; Himpe E; Potikanond S; Coppens A
    Growth Horm IGF Res; 2007 Oct; 17(5):383-91. PubMed ID: 17513150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.